Select your language

    Select a Company

    Glaxo Smithkline Consumer Nigeria Plc

    Health Care Pharmaceuticals & BiotechnologyDelisted

    17.00 NGN     0 / 0%
    As of 02-Feb-2024

    Prev. Close

    17.00

    Volume

    0

    Turnover

    NGN 0.00

    Deals

    --

    Shares Outstanding

    1,195.88 mln

    Market Cap.

    NGN 20,329.90 mln


    Loading Chart ...


    52W RANGE

    5.75 - 17.00

    1W

    --

    1M

    --

    3M

    +41.67%

    YTD

    --

    1Y

    +161.54%


    loading...

    About the company

    GlaxoSmithKline Consumer Nigeria Plc is a Nigeria-based research-based pharmaceutical and healthcare company. The principal activities of the Company are manufacturing, marketing and distribution of consumer healthcare and pharmaceutical products.


    Website
    www.gsk.com.ng
    customercare_ch_nigeria@gsk.com


    SYMBOL
    GLAXOSMITH
    ISIN
    NGGLAXOSMTH8
    Founded
    1971
    Listed
    -0001
    Phone
    (+234) 1 2711 000
    FAX
    -

    1, Industrial Avenue, Ilupeju, P.M.B 21218, Ikeja, Lagos, Nigeria


    Competitors

    Pharma-Deko Plc1.83--
    May & Baker Nigeria Plc7.65--
    Me Cure Industries Plc11.45--
    Fidson Healthcare Plc15.40--
    Juli Plc10.30--
    Neimeth International Pharmaceuticals Plc2.16-0.92%

    Research & Analysis

    NGX | Afrinvest Weekly Stock Recommendation - October 28, 202428 Oct. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - September 2024 : Global equities rally on monetary policy decision; Energy stocks improve sentiment in local equities9 Oct. 2024
    NGX | Nigerian Cement mid-year outlook - Public demand to boost topline amid cost pressures4 Oct. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - August 2024 : US Fed’s dovish signaling excites global markets; Cement sector drags local equities5 Sep. 2024
    NGX | Weekly Roundup and Stock Recommendations - August 26, 202426 Aug. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - July 2024 : Rate cut expectation drives rotation into small caps; bearish bias in local equities7 Aug. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - April 2024 : The bears dominate performance across markets9 May. 2024
    NGX | Nigerian Exchange - Monthly Equities Report - March 2024 : Sustained bullish sentiments across markets4 Apr. 2024
    NGX | Afrinvest Weekly Stock Recommendation - April 2, 20242 Apr. 2024
    NGX | Banking Sector Update - Nigerian banks expected to recapitalise2 Apr. 2024

    Annual & Financials Reports

    Annual Report 2021
    Annual Report 2020
    Annual Report 2019
    Financial Statements2018
    Annual Report 2018
    Annual Report 2017
    Financial Statements2017
    Annual Report 2016
    Financial Statements2016
    Annual Report 2015
    Financial Statements2015
    Annual Report 2014
    Annual Report 2013
    Annual Report 2012
    Annual Report 2011
    Annual Report 2010
    Annual Report 2009
    Annual Report 2008

     

    0.55 NGNFinal8 Jun. 2023
    0.45 NGNFinal27 May. 2022
    0.4 NGNFinal28 May. 2021
    0.55 NGNFinal24 Jul. 2020
    0.5 NGNFinal24 May. 2019
    7.1 NairaSpecial25 May. 2018
    0.4 NairaFinal25 May. 2018
    0.3 NGN1 Jun. 2017
    0.6 NGNSpecial12 Oct. 2016
    0.3 NGN24 Jun. 2016
    0.75 NGN12 Jun. 2015
    1.3 NGN12 Jun. 2014

    Coming Soon

    Subscribe to our Newsletter

    Login